🇺🇸 FDA
Patent

US 6987176

Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization

expired A61KA61K39/00A61P

Quick answer

US patent 6987176 (Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization) held by United States of America as represented by the Secretary of the Air Force expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/00, A61P, A61P25/02, A61P31/04